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The  control  of  blood  ﬂow during  exercise  involves  different  mechanisms,  one  of  which  is  the  activa-
tion  of  the renin-angiotensin  system,  which  contributes  to  exercise-induced  blood  ﬂow  redistribution.
Moreover,  although  angiotensin  II (Ang  II) is  considered  a potent  venoconstrictor  agonist,  little  is  known
about its effects  on  the venous  bed  during  exercise.  Therefore,  the present  study  aimed  to  assess  the
Ang  II responses  in  the  femoral  vein  taken  from  sedentary  and  trained  rats  at rest  or subjected  to a  sin-
gle  bout  of exercise  immediately  before  organ  bath  experiments.  Isolated  preparations  of  femoral  veins
taken  from  resting-sedentary,  exercised-sedentary,  resting-trained  and  exercised-trained  animals  were
studied  in an  organ  bath.  In parallel,  the  mRNA  expression  of  prepro-endothelin-1  (ppET-1),  as  well  as
the ETA and  ETB receptors,  was  quantiﬁed  by  real-time  PCR in  this  tissue.  The results  show  that,  in the
presence  of L-NAME,  Ang  II responses  in resting-sedentary  animals  were  higher  compared  to the other
groups.  However,  this  difference  disappeared  after  co-treatment  with  indomethacin,  BQ-123  or  BQ-788.ein Moreover,  exercise  reduced  ppET-1  mRNA  expression.  These  reductions  in  mRNA  expression  were  more
evident in  resting-trained  animals.  In conclusion,  either  acute  or repeated  exercise  adapts  the  rat  femoral
veins,  thereby  reducing  the  Ang  II responses.  This  adaptation  is  masked  by the  action  of  locally  produced
nitric  oxide  and  involves,  at  least  partially,  the  ETB-  mediated  release  of  vasodilator  prostanoids.  Reduc-
tions in  endothelin-1  production  may  also  be  involved  in these  exercise-induced  modiﬁcations  of  Ang  II
responses  in the  femoral  vein.. Introduction
The control of blood ﬂow during exercise involves different
echanisms, including the activation of the sympathetic ner-
ous system and the release of local vasoactive mediators [40].
dditionally, prior evidence indicates the participation of the renin-
ngiotensin system in the active modiﬁcation of vascular tonus
hereby contributing to the exercise-induced redistribution [17]. In
he cardiovascular system, angiotensin II (Ang II), which is consid-
red an important effector of this system, may  work independently
r in association with the sympathetic nervous system [2]. More-
ver, depending on the vascular territory, Ang II responses may
e modulated by other local mediators such as prostanoids, nitric
xide (NO) and endothelin-1 (ET-1) [4,15,35].
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To achieve a better understanding of circulatory redistribu-
tion during exercise, it is necessary to understand the venous
bed in detail. The venous bed is considered the primary compart-
ment of capacitance in mammals because it stores approximately
60–80% of blood volume during rest [33]. This blood volume is
rapidly shifted through the veins toward the heart during exercise-
induced circulatory redistribution [38]. In this regard, some authors
have proposed that active venoconstriction evokes a rapid self-
contained blood transfusion to the stressed volume, maintaining or
increasing the end-diastolic volume during exercise [32]. However,
Rowell [34] argues that venoconstriction would cause a proportion-
ally much larger alteration in resistance to ﬂow, thereby impairing
the venous return.
Although Ang II is considered a potent venoconstrictor ago-
nist, little is known about its effects on the venous bed during
exercise. Trained rats subjected to a single bout of exercise exhib-
ited increased Ang II responses on the portal vein but not on the
Open access under the Elsevier OA license.inferior vena cava, which suggests a territory-speciﬁc adaptation
[3]. Interestingly, the portal vein receives the blood volume from
the splanchnic territory, where previous studies agree that active
venoconstriction participates in exercise-enhanced venous return
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10,32]. Thus, for a better understanding of the effects of exercise
n the venous bed, it is necessary to investigate veins that received
lood from musculocutaneous circulation where the absence of
ppreciable venoconstriction may  actually be beneﬁcial because
t impedes an uncontrolled increase in the resistance to the cen-
ripetal ﬂow [34].
Therefore, the present study aimed to assess the Ang II responses
n the femoral vein taken from sedentary and trained rats at rest or
ubjected to a single bout of exercise immediately before organ
ath experiments. The involvement of prostanoids, NO and ET-
 in exercise-induced modiﬁcations was also investigated in the
emoral vein.
. Material and methods
.1. Animals
One hundred forty-two male Wistar rats (350–450 g) were
oused in plastic cages (50 cm × 40 cm × 20 cm)  with ﬁve animals
er cage. Food and water were available ad libitum. During the exer-
ise protocol, rats were maintained in the training room under a
2 h light-dark cycle, with lights on at 07:00 h. Room temperature
as maintained at 25 ◦C. Rats were used in accordance with eth-
cal principles [9], and the study was approved by the Research
thics Committee of the School of Medicine at Marília (Protocol n◦
51/09).
.2. Exercise protocol
The exercise protocol used was based on a previous study [25].
rieﬂy, animals were subjected to the maximal exercise test on a
readmill (Movement Technology LX 170) to determine their ability
o run on the treadmill. Based on the results of this test, the ani-
als were randomly assigned to sedentary or trained groups with a
imilar average of maximal exercise capacity in both groups. Then,
he animals designated as trained were exercised 5 days per week
or 1 h per day for 8–12 weeks. The exercise intensity was progres-
ively increased by a combination of time and velocity, attaining
 h per day at a velocity correspondent to 60% of maximal exercise
y the third week. This protocol has been deﬁned as constituting
ow-intensity physical training [21,25]. All of the animals used in
he present study increased their maximal exercise capacity from
he ﬁrst to the sixth week, when the maximal exercise tests were
epeated. This improvement of physical conditioning was consid-
red an indirect indication of the efﬁcacy of the physical training.
Two groups of sedentary and two groups of trained animals were
ubjected to the organ bath experiments in parallel. One group of
edentary and one group of trained animals were studied at rest,
esignated resting-sedentary and resting-trained animals, respec-
ively. The other two groups of sedentary and trained animals
nderwent a single bout of exercise immediately before the organ
ath experiments. These animals were designated as exercised-
edentary and exercised-trained, respectively.
.3. Organ bath studies
Animals were killed in a CO2 chamber and exsanguinated. The
emoral vein (3–4 mm;  two rings per animal) was prepared and set
p in 2 mL  organ baths. Rings were ﬁxed to a stainless-steel hook
ttached to a stationary support as well as to a hook connected to an
sometric force transducer. Rings were bathed in Krebs–Henseleit
olution (composition in mmol/L): NaCl 130; KCl 4.7; CaCl2 1.6;
H2PO4 1.2; MgSO4 1.2; NaHCO3 15; glucose 11.1). The solution
as kept at pH 7.4 and 37 ◦C and bubbled continuously with a
ixture of 95% O2 and 5% CO2. Tension was monitored continu-
usly and recorded using a Powerlab 8/30 data-acquisition systems 44 (2013) 47–54
(ADInstruments, Castle Hill, NSW, Australia). Prior to administer-
ing drugs, rings were equilibrated for 60 min  at a resting tension
of 0.5 g. The time frame from the end of the exercise sessions to
the beginning of the Ang II cumulative concentration–response
curves was approximately 90 min.The responses (g) evoked by
cumulatively adding Ang II (10−11 mol/L – 10−7 mol/L; Sigma) or
ET-1 (10−11 mol/L – 10−6mol/L; Sigma) directly into the organ
bath were plotted to obtain concentration–response curves. The
actions of Ang II were also evaluated by pretreating the rings for
20 min  with 10−4 mol/L L-NAME and 10−5 mol/L indomethacin,
non-selective nitric oxide synthase and cyclooxygenase inhibitors
(Sigma), respectively, 10−6 mol/L BQ-123 (antagonist of endothelin
receptor type A - ETA; Sigma) or 10−6 mol/L BQ-788 (antagonist of
endothelin receptor type B – ETB; Sigma). All drugs were admin-
istered directly to the organ bath. Non-linear regressions (variable
slope) for these curves revealed the Rmax (maximal response; high-
est point of each concentration–response curve) and the pEC50
(negative logarithm of the concentration that evoked 50% of the
maximal response). The pEC50 is indicative of the sensitivity of the
system to the drug studied.
2.4. RNA extraction and cDNA synthesis
Total RNA was  extracted from frozen femoral vein samples
using TRIZOL (Life Technologies, Gaithersburg, MD,  USA), following
the manufacturer’s instructions. Total RNA was quantiﬁed using a
NanoDrop Spectrophotometer – 2000 (NANODROP, USA). The con-
centrations were adjusted, and the samples were stored at −80 ◦C
until use. cDNA synthesis was  carried out using High-Capacity
cDNA Reverse Transcription Kits (Applied BiosystemsTM, USA), fol-
lowing the protocol provided by the manufacturer. All cDNA was
quantiﬁed using a NanoDrop Spectrophotometer – 2000 (NANO-
DROP, USA). The concentrations were adjusted, and samples were
stored at −80 ◦C.
2.5. Gene expression analysis
All gene expression was  measured by qRT-PCR on the
Applied Biosystems 7500 Fast Real-Time PCR system (Applied
BiosystemsTM, USA), using the cycling conditions recommended
by Applied Biosystems. We  used the following assays: preproET-
1 (ppET-1)– Assay ID: Rn00561129 m1*, ETA – Assay Id:
Rn00561137 m1*, ETB – Assay Id: Rn00569139 m1*  and GAPDH
- Assay ID: Rn99999916 s1.
The threshold values were uniformly set for all assays. All
reactions were performed in duplicate. Replicates with standard
deviations (SD) higher than 0.5 for the cycle threshold (CT) value
were repeated or excluded from the analysis.
The ampliﬁcation curve of each group was  determined, and the
CT values were obtained for all genes (ppET-1, ETA, ETB and GAPDH).
We used the comparative CT method (CT method), where we
ﬁrst calculated CT = CT target – CT endogenous controls to nor-
malize the target gene to the endogenous controls. Notably, the
Relative Quantiﬁcation (RQ) of ppET-1, ETA, ETB genes was calcu-
lated using the control group as a reference and using the 2-CT
formula, which provides the percentage change, or how much more
one gene is expressed in one group relative to another. All CT val-
ues were obtained using 7500 software 2.0, and these data were
exported to Microsoft Excel (Microsoft, USA) to calculate 2-CT
and RQ.
2.6. Statistical analysisThe data are presented as the mean ± SEM. The Rmax and pEC50
values were compared by two-way ANOVA followed by Bonfer-
roni’s post-test because one variable was  the physical training and
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Fig. 1. Ang II concentration-response curves determined in circular preparations of the femoral vein taken from resting-sedentary (RS), exercised-sedentary (ES), resting-
trained  (RT) and exercised-trained (ET) rats, treated with saline (A), 10−5 mol/L indomethacin (INDO; B), 10−4 mol/L L-NAME (C) or 10−4 mol/L L-NAME and 10−5 mol/L INDO
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nimals; #indicates a signiﬁcant difference (P < 0.01) in relation to the RT animals, r
he other was exposure to a single exercise session. P < 0.05 were
onsidered statistically signiﬁcant.
. Results
The Ang II responses in femoral veins are discrete and difﬁcult
o measure. Therefore, the Ang II concentration-response curves in
he femoral veins are characteristically low. These curves exhibited
 similar pattern in both sedentary and trained animals, whether
tudied at rest or after a single bout of exercise (Fig. 1A). Dif-
erences between groups were not observed in the presence of
ndomethacin either (Fig. 1B). In the presence of L-NAME, how-
ver, the Ang II concentration-response curves determined for
esting-sedentary animals as well as the related Rmax values were
igher compared to the other groups (Fig. 1C). However, in the
resence of both L-NAME and indomethacin, preparations taken
rom exercised-sedentary, resting-trained and exercised-trained
nimals exhibited Ang II concentration-response curves of similar
agnitude to preparations taken from resting-sedentary animals
Fig. 1D). Indeed, the difference in the Ang II Rmax observed between
roups in the presence of L-NAME disappeared in the presence
f both L-NAME and indomethacin. Notably, the pEC50 values
ould not be calculated in concentration-response curves with very
ow magnitudes. However, in preparations treated with both L-
AME and indomethacin, for which this parameter was calculated,s in parentheses. *Indicates a signiﬁcant difference (P < 0.01) in relation to the ES
tively (two-way ANOVA followed by Bonferroni’s post-test).
neither physical training nor a single bout of exercise changed the
Ang II pEC50 (Table 1).
In presence of L-NAME and BQ-123 (Fig. 2A), the Ang II
concentration-response curves determined in resting-sedentary
animals, which were higher in presence of L-NAME only (Fig. 1C),
became similar to those obtained in the other groups. This
occurred because co-treatment with BQ-123 attenuated the Ang II
concentration-response curves determined in preparations taken
from resting-sedentary animals and, in parallel, increased the
Ang II concentration-response curves determined in preparations
taken from the other groups. On the other hand, the treat-
ment with L-NAME and BQ-788 (Fig. 2B) elevated the Ang II
concentration-response curves in the preparations taken from
exercised-sedentary animals as well as resting-trained and exer-
cised trained animals, thereby suppressing the differences of Ang II
Rmax observed in the presence of L-NAME alone (Fig. 1C). Moreover,
co-treatment with BQ-123 or BQ-788 did not cause any exercise-
induced change in the Ang II pEC50 (Table 1).
Neither physical training nor the exposure of trained or seden-
tary animals to a single bout of exercise modiﬁed the Ang II
concentration-response curves that were determined in prepa-
rations treated simultaneously with L-NAME, indomethacin and
BQ-123 (Fig. 3A) or BQ-788 (Fig. 3B). Furthermore, no changes
were evidenced in terms of pEC50 (Table 1). However, the Ang
II concentration-response curves obtained in preparations treated
concomitantly with L-NAME, indomethacin and BQ-788 (Fig. 3B)
50 A.B. Chies et al. / Peptides 44 (2013) 47–54
Table 1
Ang II pEC50 determined in femoral veins taken from resting-sedentary (RS), exercised-sedentary (ES), resting-trained (RT) and exercised-trained (ET) rats.
RS ES RT ET
Saline nd nd nd nd
Indomethacin nd nd nd nd
L-NAME 8.71 ± 0.81 (10) nd nd nd
L-NAME/Indomethacin 8.78 ± 0.29 (14) 8.43 ± 0.28 (12) 8.91 ± 0.21 (13) 8.87 ± 0.33 (14)
L-NAME/BQ-123 9.08 ± 0.18 (08) 8.87 ± 0.33 (08) 9.52 ± 0.66 (06) 9.23 ± 0.30 (06)
L-NAME/BQ-788 8.53 ± 0.64 (08) 9.09 ± 0.16 (06) 9.18 ± 0.21 (06) 9.00 ± 0.28 (07)
BQ-788/L-NAME/Indomethacin 9.25 ± 0.34 (08) 9.48 ± 0.79 (08) 8.83 ± 0.21 (07) 9.10 ± 0.21 (07)
BQ-788/L-NAMEIndomethacin 9.01 ± 0.20 (07) 9.37 ± 0.33 (07) 8.94 ± 0.29 (06) 8.79 ± 0.19 (06)
Data express as mean ± SEM and, between parentheses, the number of independent determinations. “nd” means that Ang II pEC50 were not determined.
Fig. 2. Ang II concentration-response curves determined in circular preparations of the femoral vein taken from resting-sedentary (RS), exercised-sedentary (ES), resting-
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arained (RT) and exercised-trained (ET) rats, treated with 10−4 mol/L L-NAME and 1
he  mean ± SEM, and the number of independent determinations is presented in pa
ere higher than those obtained in the absence of BQ-788 (Fig. 1D).
he elevations of Ang II Rmax induced by BQ-788 were statisti-
ally signiﬁcant only in preparations taken from resting-sedentary
nimals (P < 0.05; two-way ANOVA followed by Bonferroni’s post-
est).ET-1 evokes stronger contractions of femoral veins, although it
s required in higher concentrations, compared to Ang II. However,
he obtained concentration-response curves were not modiﬁed
y training or by the single bout of exercise. Thus, the curves
ig. 3. Ang II concentration-response curves determined in circular preparations of femor
RT)  and exercised-trained (ET) rats treated with 10−4 mol/L L-NAME, 10−5 mol/L indome
nd  10−6 mol/L BQ-788 (B). Points represent the mean ± SEM, and the number of indepenol/L BQ-123 (A) or 10−4 mol/L L-NAME and 10−6 mol/L BQ-788 (B). Points represent
eses.
obtained in these groups of animals exhibited similar values of Rmax
(Fig. 4) and pEC50 (7.79 ± 0.17 in resting-sedentary; 7.75 ± 0.18 in
exercised-sedentary; 7.82 ± 0.14 in resting-trained; 7.87 ± 0.20 in
exercised-trained).
ppET-1 mRNA expression in femoral veins was  reduced by a
single bout of exercise as well as the physical training. Although
an overall trend was exhibited, this reduction was statistically
signiﬁcant only in the resting-trained animals (Fig. 5A). A sim-
ilar reduction of ETA mRNA expression, though non-signiﬁcant,
al vein taken from resting-sedentary (RS), exercised-sedentary (ES), resting-trained
thacin (INDO) and 10−6 mol/L BQ-123 (A) or 10−4 mol/L L-NAME, 10−5 mol/L INDO
dent determinations is presented in parentheses.
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Fig. 4. ET-1 concentration-response curves determined in circular preparations
of  the femoral vein taken from resting-sedentary (RS), exercised-sedentary
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Fig. 5. Relative expression of ppET-1 (A) as well as ETA (B) and ETB (C) mRNA
detected in portal veins taken from resting-sedentary (RS), exercised-sedentary (ES),
resting-trained (RT) and exercised-trained (ET) rats. Bars represent the mean ± SEM,
and the number of independent determinations is presented in parentheses. *Indi-ES), resting-trained (RT) and exercised-trained (ET) rats. Points represent the
ean ± SEM, and the number of independent determinations is presented in paren-
heses.
as detected in femoral veins taken from resting-trained animals
Fig. 5B). On the other hand, neither physical training nor the sin-
le bout of exercise signiﬁcantly modiﬁed ETB mRNA expression in
emoral veins (Fig. 5C).
. Discussion
Dynamic exercise may  increase plasma Ang II concentration
39]. Moreover, it has been proposed that the renin-angiotensin
ystem may  participate in the active modiﬁcations of vascular tonus
uring exercise, thereby contributing to blood redistribution [17].
t has already been proposed that Ang II actions throughout the
ardiovascular system may  be inﬂuenced by local mediators such
s prostanoids, NO and ET-1 [4,15,35]. Moreover, previous evi-
ence suggests that exercise modiﬁes the production of such local
ediators in vascular beds directly involved in exercise-induced
irculatory redistribution [3,23,24]. In this regard, a detailed under-
tanding of the effects of exercise on the actions of Ang II throughout
he cardiovascular system, especially on the venous bed, where
his knowledge is even scarcer, is essential to the understanding
f exercise-induced circulatory redistribution.
Here, Ang II responses were discrete in rat femoral veins,
esulting in ﬂattened concentration-response curves and low Rmax
alues. The pEC50 values were not determined in these curves
ecause they did not always assume a sigmoidal conformation. This
attern of Ang II response is markedly lower compared to other
arge central veins (data not shown) and appears not to be related
o tachyphylaxis because only one curve for Ang II was determined
or each preparation in the present study.
Not only can the pattern of response to Ang II vary depending
n the vascular bed, but the effects of exercise on the vasomotor
esponses to this vasoactive peptide may  also be territory-speciﬁc.
t has been demonstrated that physical training causes adaptations
n the rat portal vein, causing it to respond vigorously to Ang
I even during exercise. These modiﬁcations of Ang II responses
ere not observed in the vena cava, suggesting a territory-speciﬁc
daptation [3]. In the present study, neither physical training nor a
ingle bout of exercise changed the Ang II vasomotor responses in
emoral veins, which reinforces the concept that exercise effects
re territory-speciﬁc. Inasmuch as the femoral vein drains the
lood volume from musculocutaneous circulation toward the venacates a signiﬁcant difference (P < 0.05) in relation to the RS animals (two way ANOVA
followed by Bonferroni’s post-test).
cava, lower Ang II responses in this venous bed may be of beneﬁt
to assure venous return during exercise because they may  prevent
an uncontrolled increase in the resistance to ﬂow [10,34].
The Ang II responses in femoral veins taken from resting-
sedentary animals did not change in the presence of indomethacin.
However, such responses increased in presence of L-NAME
compared to the preparations taken from exercised-sedentary,
resting-trained or exercised-trained animals. Interestingly, co-
treatment with L-NAME and indomethacin increased the Ang II
responses in femoral veins taken from animals subjected to differ-
ent exercise protocols, causing responses of similar magnitude to
preparations taken from resting-sedentary animals. This indicates
that the Ang II responses in femoral veins are constantly modu-
lated by NO in animals that have not exercised. However, both a
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ingle bout of exercise and physical training mobilizes vasodila-
or prostanoids to participate with NO in a redundant fashion [26]
n the Ang II responses in femoral veins are modulated. Assuming
hat the Ang II responses in the femoral vein must be constantly
odulated to avoid an uncontrolled increase in the resistance of
lood ﬂow in the body, prostanoids apparently serve as a backup
echanism during exercise [7].
Vasodilator prostaglandins have also been shown to counter-
ct renal actions of endogenous Ang II in sodium-depleted humans
hen NO synthesis is inhibited [30]. Other studies suggest that,
epending on the vascular territory, prostaglandins are even more
mportant than NO in modulating the hemodynamic responses to
ng II [1,6,36]. In parallel, it was suggested that shear stress may
educe the tone of skeletal muscle venules by releasing endothelial
O and prostanoids [13]. The inﬂuence of exercise-induced shear
tress upon the interaction between Ang II, NO and vasodilator
rostanoids was also proposed in the rat portal vein [3]. There-
ore, exercise-induced shear stress may  stimulate the synthesis of
asodilator prostanoids in femoral veins, thus resulting in reduction
f Ang II responses.
The participation of ET-1 in femoral vein responses to Ang II was
lso investigated in the present study. This approach was  necessary
ecause the involvement of ET-1 in exercise-induced modiﬁcations
f Ang II responses was previously proposed in the rat portal vein
3]. Moreover, it has been reported that Ang II induces the release of
T-1 in rat aorta which, in turn, modulates the contractile responses
f this vascular bed to Ang II [28]. Thus, in the present study, the
ifference in Ang II responses observed between groups in the pres-
nce of L-NAME was suppressed by co-treatment with BQ-123.
his occurred in part because the Ang II responses in preparations
aken from resting-sedentary animals were attenuated in the pres-
nce of BQ-123. Therefore, in animals not exposed to exercise, Ang
I appears to induce the release of ET-1 in femoral veins, which
nhances the response of Ang II through the activation of ETA.
On the other hand, the presence of BQ-123 also increased Ang II
esponses in preparations taken from exercised-sedentary, resting-
rained and exercised-trained animals, suppressing the difference
bserved in the presence of L-NAME only. These data indicate that,
n femoral veins taken from animals subjected to acute or repeated
xercise, Ang II promotes release of ET-1 and this, in turn, releases
asodilator substances through ETA, thereby attenuating the Ang II
esponses. These vasodilator substances are most likely vasodilator
rostanoids because BQ-123 failed to reduce Ang II responses when
ndomethacin was added to the organ bath. Interestingly, the ETA-
ediated release of prostacyclin has already been proposed in the
at perfused lung [5] and the arterial bed of the rabbit kidney [37].
otably, in the rabbit kidney, ETA inhibition failed to reduce the Ang
I-induced release of prostacyclin, which may  indicate a territorial
spect of this mechanism.
By releasing ET-1, Ang II can also have its contractile responses
odulated by stimulation of ETB. In this regard, BQ-788 increased
he Ang II responses in femoral veins taken from exercised-
edentary as well as resting or exercised-trained animals in the
resence of L-NAME, permitting responses of similar magnitude
ith preparations taken from resting-sedentary animals. This
nding suggests that either a single bout of exercise or physical
raining attenuates the Ang II responses in femoral veins, even
n the absence of NO, at least partially enhancing ETB-mediated
asodilatation. Indeed, ET-1 may  release vasodilator substances
rom the endothelium through the activation of ETB receptors, thus
ounterbalancing the vasoconstrictor effects of ET-1 mediated by
oth ETA and ETB located on vascular smooth muscle cells [12,22].
his discussion could be further enhanced by data obtained in
ndothelium-denuded preparations. However, it was not always
ossible to remove the endothelium from the femoral veins
ecause they are small and fragile. Even when it was  possible,s 44 (2013) 47–54
the effectiveness of the endothelial removal could not be ascer-
tained because these preparations do not exhibit enough stable
precontractions to study their acetylcholine-induced relaxation.
However, the possibility cannot be excluded that the stimula-
tion of ETB may  activate mechanisms that are unrelated to NO or
vasodilator prostanoids in femoral veins. Nevertheless, in the pres-
ence of both L-NAME and indomethacin, BQ-788 increased the Ang
II responses only in femoral veins taken from resting-sedentary ani-
mals. Although slight differences were observed in femoral veins
taken from exercise-exposed animals, they were non-signiﬁcant,
indicating that mechanisms unrelated to NO or prostanoids do not
affect the Ang II responses in these preparations.
The present study assumed that the exercise-induced modiﬁca-
tions of Ang II responses in femoral veins involved ET-1, given that
it has previously been postulated that exercise promotes hemody-
namic changes through the modulation of ET-1 production [16,19].
However, the involvement of endothelins-2 and -3 in this phe-
nomenon cannot be discounted because such peptides can also bind
to both ETA and ETB, though with different afﬁnities [12].
Although the ETA mRNA expression appeared to have been
reduced in trained animals, this difference was non-signiﬁcant.
Similarly, ETB mRNA expression was not modiﬁed by any of the
employed exercise protocols. Coincidentally, the ET-1 contractile
responses in femoral veins were not modiﬁed by exercise either.
On the other hand, physical training reduced the mRNA level of
ppET-1, a precursor of ET-1, in femoral veins. Real-time PCR was
chosen to investigate the local expression of ppET-1, ETA and ETB
because rat femoral veins are too small to employ direct meth-
ods to quantify peptides. However, because real-time PCR does not
measure protein synthesis, such results must be analyzed together
with those obtained in functional experiments. Nevertheless, these
data strongly indicate that ET-1, but not its receptors, is synthe-
sized in lower amounts in the femoral veins of animals subjected
to exercise.
The reduction of ET-1 production in the femoral vein, if it did
in fact occur, may  have been due to the exercise-induced eleva-
tion of shear stress. It has been reported that ET-1 production
may  vary depending on the time or the level of shear stress to
which the endothelial cells are exposed [14]. According to these
authors, higher shear stress levels reduce the release of ET-1
in cultured of human umbilical vein endothelial cells. Similarly,
shear stress decreased the ppET-1 mRNA expression in a time and
dose-dependent manner in both cultured human umbilical vein
endothelial cells [27] and in cultured human retinal microvascular
endothelial cells [11].
Although it has been extensively studied, the effects of shear
stress on the local expression of ET-1 remain controversial. Some
studies suggest that high levels of shear stress decrease the pro-
duction of ET-1 in several cultured endothelial cells, while others
show the opposite [41,42]. These conﬂicting data reﬂect the com-
plexity of the mechanisms that modulate the expression of these
genes, wherein the intensity and time of exposure to shear stress
are the determining variables. Interestingly, the reduction in ppET-
1 mRNA expression in femoral veins reached statistical signiﬁcance
only in animals exposed to physical training at 24 h after the last
session. This ﬁnding indicates that a reduction in trained animals
may  be a ﬂoating phenomenon and that the peak comes after a
rest period. Thus, data extrapolations from a speciﬁc vascular bed
or from cells in culture to the entire cardiovascular system must
be performed carefully. Moreover, it reinforces the importance of
studying the effects of exercise on different portions of the cardio-
vascular system, including femoral veins.Tissue-speciﬁc modiﬁcations of ET-1 expression have been pre-
viously proposed to be involved in the integrated physiological
response during exercise [18–20]. Possibly, in vascular beds where
exercise elevates blood ﬂow, as in the femoral vein, the reduction of
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T-1 expression avoids an uncontrolled increase in ﬂow resistance.
owever, organ bath experiments demonstrated that in absence of
O, the ETB-mediated release of vasodilator prostanoids appears
o maintain reduced Ang II responses in femoral veins taken from
xercised animals. Perhaps, though the local ET-1 expression may
e reduced, its effects on the endothelial release of prostanoids
ediated by ETB may  be increased in femoral veins during exercise.
However, an increase in ET-1 production or its release from
he Weibel-Palade Bodies [8,29,31] cannot be discarded in femoral
eins taken from animals exposed to exercise that were challenged
ith high Ang II concentrations. It is possible that higher concen-
rations of ET-1 may  paradoxically reduce the Ang II responses in
emoral veins through the activation of ETB. Unfortunately, due to
ethodological limitations, this hypothesis was not tested. Fur-
hermore, the integrity of mRNA obtained from femoral veins
ncubated in nutrient solution containing Ang II was  impaired,
recluding the application of real-time PCR to these samples.
herefore, although many aspects of exercise-induced adaptations
n femoral veins have been clariﬁed in the present study, this
nvestigation is not ﬁnished. In this respect, the present study
ay  generate further investigations involving other experimental
pproaches.
. Conclusions
In conclusion, the present study suggests that either acute or
epeated exercise adapts the rat femoral vein, thereby reducing
he Ang II responses. This adaptation is masked by the action of NO
roduced locally and involves, at least partially, the ETB-mediated
elease of vasodilator prostanoids. Reductions in ET-1 production
ay  also be involved in these exercise-induced modiﬁcations of
ng II responses in the femoral vein. Finally, these mechanisms act
oordinately to keep the femoral vein response to Ang II under con-
rol even in the absence of NO, thus ensuring an adequate venous
eturn during exercise.
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